-A rare, fatal intestinal disease that victimizes infants resulting in poor quality of life and a short lifespan if not diagnosed and treated- HAMDEN, Conn., February 28, 2019 — Vanessa Research VR) – a Connecticut-based biomedical company discovering, developing, and commercializing innovative products in areas of unmet medical needs – announced today the publication of…

Hamden, CT – Vanessa Research, Inc. (VRI) is pleased to announce that its MIDA™ (Microvillus Inclusion Disease Assay) project, under the direction of Dr. Ludmila Kvochina, has been accepted into the 2019 cohort of the highly selective Accelerator for Biosciences in Connecticut (ABCT). MIDA™ is the first-ever dipstick test developed to screen for the incredibly…

Hamden, CT – Vanessa Research Inc. (VRI) is pleased to announce the launch of its educational website focused on microvillus inclusion disease (MVID) translated into the Arabic language. The website explains the mechanism of MVID, provides targeted resources both for doctors and caregivers, and publishes new scientific research and other pertinent news and information related…

Hamden, CT – Vanessa Research Inc. (VRI) is pleased to announce the launch of its educational website focused on microvillus inclusion disease (MVID) translated into the Turkish language. The website explains the mechanism of MVID, provides targeted resources both for doctors and caregivers, and publishes new scientific research and other pertinent news and information related…